Type 1 Diabetes Tied to Gut Inflammation, Microbiota

Share this content:
Type 1 Diabetes Tied to Gut Inflammation, Microbiota
Type 1 Diabetes Tied to Gut Inflammation, Microbiota

FRIDAY, Jan. 20, 2017 (HealthDay News) -- Patients with type 1 diabetes exhibit inflammation in the digestive tract and gut bacteria in a pattern that differs from individuals who do not have diabetes or those who have celiac disease, according to a study published online Jan. 19 in the Journal of Clinical Endocrinology & Metabolism.

The study included 54 people who had endoscopies and biopsies of the duodenum. The endoscopic procedures were performed at San Raffaele Hospital in Milan between 2009 and 2015. Nineteen study participants had type 1 diabetes. Sixteen healthy study participants served as a control group. The last 19 had celiac disease.

The team found that patients with type 1 diabetes had significantly more inflammation in the mucous membrane of the gut linked to 10 specific genes than those with celiac disease or people in the control group. The patients with type 1 diabetes also showed a different and distinct combination of gut bacteria.

"This study shows that duodenal mucosa in type 1 diabetes presents disease-specific abnormalities in inflammatory profile and microbiota," the authors write. "Understanding the mechanisms underlying these features is critical to disentangle the complex pathogenesis of type 1 diabetes and indicate new perspectives for future therapies targeting the intestine."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

First drug to be approved for rare autoimmune disease that leads to vasculitis

Findings Support Individualized Glycemic Control in T2DM

Findings Support Individualized Glycemic Control in T2DM

Approach saved $13,547/patient vs uniform intensive control, with lower medication costs

Atherosclerosis ID'd in Many Without CV Risk Factors

Atherosclerosis ID'd in Many Without CV Risk Factors

LDL-C independently associated with the presence and extent of atherosclerosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »